-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, S7nCA9pw9TndHw14YH755os2ICYk5x2Uuyn5GVwS6IoMdAE7vLJR0+c/1dDu4+xZ yQCZ5gYIlMuLvlgbIyFz2g== 0001127602-09-014282.txt : 20090619 0001127602-09-014282.hdr.sgml : 20090619 20090619100614 ACCESSION NUMBER: 0001127602-09-014282 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20090617 FILED AS OF DATE: 20090619 DATE AS OF CHANGE: 20090619 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000729922 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133159796 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 PINELAWN ROAD CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 631-962-2000 MAIL ADDRESS: STREET 1: 41 PINELAWN ROAD CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENE SCIENCE INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STEVENSON KATHARINE BERGHUIS CENTRAL INDEX KEY: 0001232227 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15190 FILM NUMBER: 09900092 MAIL ADDRESS: STREET 1: C/O NORTEL NETWORKS CORPORATION STREET 2: 8200 DIXIE ROAD STE 100 CITY: BRAMPTON ONTARIO STATE: A6 ZIP: L6T 5P6 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2009-06-17 0000729922 OSI PHARMACEUTICALS INC OSIP 0001232227 STEVENSON KATHARINE BERGHUIS C/O OSI PHARMACEUTICALS, INC. 41 PINELAWN ROAD MELVILLE NY 11747 1 Common Stock 2009-06-17 4 A 0 2500 0 A 11490 D Stock Option (Right to Buy) 28.65 2009-06-17 4 A 0 7500 0 A 2010-06-17 2016-06-16 Common Stock 7500 7500 D Represents the formula grant of Restricted Stock to the director upon re-election to the Board of Directors of OSI Pharmaceuticals, Inc. 25% of the Restricted Stock will vest one year after the date of grant and the remainder will vest ratably on an annual basis over the succeeding 3 years. 25% of the option will become exerciseable one year after the date of grant and the remainder will vest ratably on an annual basis over the succeeding 3 years. Includes only options with the same termination date. Exhibit List Exhibit 24--Power of Attorney /s/ Pierre Legault, attorney-in-fact for Ms. Stevenson 2009-06-19 EX-24 2 doc1.txt POWER OF ATTORNEY POWER OF ATTORNEY Know all by these presents that the undersigned hereby constitutes and appoints Pierre Legault with full power of substitution and re-substitution, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of OSI Pharmaceuticals, Inc. (the "Company") Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Act of 1934, and the rules thereunder: (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, Form 4 or Form 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney in fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney- in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorneys-in-fact substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of, and transactions in securities issued by the Company unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney as of this 6th day of January, 2009. By: /s/ Katharine B. Stevenson -----END PRIVACY-ENHANCED MESSAGE-----